Neil Dahiya

Vensana Capital has successfully wrapped up a $425 million Fund III to further invest in pioneering medtech firms. Based in Edina, Minnesota, the venture capital firm disclosed yesterday that it now manages approximately $1 billion in assets. This development is

CapsoVision has revealed that the FDA has granted approval for its CapsoCam Plus system to be used with children aged two and up. This innovative system offers a non-invasive and comfortable endoscopy experience through a capsule device. Hailing from Saratoga,

Relief Cardiovascular has successfully raised $12 million in a Series A funding round to spearhead its first-in-human feasibility study for the innovative Relief System. This smart transcatheter implant, developed by the Costa Mesa-based company, aims to revolutionize heart failure fluid

Johnson & Johnson MedTech (NYSE: JNJ) announced its dual-energy ThermoCool SmartTouch SF catheter has achieved CE mark certification. The catheter, characterized by its irrigated, contact force-sensing features, collaborates with the TruPulse generator, both of which fully integrate with the Carto

Saluda Medical has announced a successful $100 million funding round to further develop its innovative closed-loop, dose-control neuromodulation platform. The financing was spearheaded by existing stakeholder Redmile Group, with contributions from current investors such as Wellington Management, TPG Life Sciences

Pulse Biosciences (Nasdaq:PLSE) announced today the appointment of Paul A. LaViolette, the co-chair of its board, as the company’s new Chief Executive Officer. LaViolette steps in for Burke T. Barrett, who resigned on December 6th after a tenure of just

BD (NYSE: BDX) has made public the appointment of Pamela Spikner as the senior VP, chief accounting officer, and controller, starting January 20. Spikner’s responsibilities will include overseeing the accounting policy and financial reporting activities within BD. She will directly